On November 29th, 2022, The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) announced that its shareholders voted in favor of a resolution approving SNDL Inc.'s acquisition of all issued and outstanding common shares of Valens, on a per share basis of 0.3334 SNDL common shares for each Valens common share, subject to the terms of the arrangement agreement entered into by Valens and SNDL on August 22nd, 2022 ("Agreement"). Valens and SNDL are parties to the Agreement. At the special meeting of shareholders held on November 29th, 2022, over 96% of the votes cast were in favor of the resolution.
With this announcement, we are one step closer to the merger of two leading cannabis companies with extremely complementary assets, creating a true market leader. The newly formed company will become Canada's first large-scale vertically integrated cannabis company, combining SNDL's excellent balance sheet and Canada's largest cannabis retail network with Valens' low-cost manufacturing platform. "We look forward to taking the Valens brand to new heights and developing 2.0 products for the SNDL platform," said Tyler Robson, CEO of Valens. "We believe that this newly formed company not only offers attractive risk exposure for investors, but is also Canada's largest revenue-generating cannabis company with a book value far below its actual value, and a dominant platform that could become a global cannabis leader.
This arrangement is expected to conclude in January 2023, subject to meeting and/or waiving the termination conditions outlined in the agreement, including final court approval from the Ontario Superior Court of Justice (Commercial List).
2FIRSTS will continue to cover this topic and provide updates on the "2FIRSTS APP". Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
